Additional clinical research is needed to further validate the relevance of NF-κB tumor expression to patient prognosis in terms of recurrence and long-term survival, and clarify its role in inflammation during tumorigenesis, with or without the presence of IBD. The gene discussed is NFKB1; the disease is neoplasm.